கயில ராஸ்மஸெந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கயில ராஸ்மஸெந். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கயில ராஸ்மஸெந் Today - Breaking & Trending Today

Lifting FDA restrictions on mifepristone could normalize medication abortion

Lifting FDA restrictions on mifepristone could normalize medication abortion
In a new study published online in spring 2021 and in the July issue of the journal
Contraception, University of Chicago Medicine investigators and colleagues interviewed primary care providers in Illinois about their interest in providing medication abortion care and found that lifting FDA restrictions on mifepristone to allow pharmacy dispensing could normalize medication abortion, facilitate its use in primary care facilities, and address disparities in reproductive health access.
Mifepristone is used in combination with misoprostol to end early pregnancies, during the first trimester, said senior author Debra Stulberg, MD, MAPP, Chair of the Department of Family Medicine at the UChicago Medicine. The two-drug regimen is safe and highly effective, but access is limited by a strict Risk Evaluation and Mitigation Strategy (REMS) that prohibits pharmacy dispensing of mifepristone. ....

United States , University Of Chicago , Danielle Calloway , Elizabeth Janiak , Debra Stulberg , Kayla Rasmussen , Emily Henderson , American Academy Of Family Physicians , American College Of Obstetricians , Pritzker School Of Medicine , Department Of Family Medicine , University Of Chicago Medicine , Harvard Medical School , Chicago Medicine , Family Medicine , Risk Evaluation , Mitigation Strategy , Study First Author , Medical Student , Pritzker School , Harvard Medical , American College , American Academy , Family Physicians , Medical School , Primary Care ,

Study finds physicians support pharmacy dispensing to expand access to medication abortion

Interviews with primary care providers showed support for removal of the FDA s mifepristone Risk Evaluation and Mitigation Strategy, which prevents pharmacists from dispensing the drugs needed for medication abortions. ....

University Of Chicago , United States , Hyde Park , Orland Park , Bernard Mitchell Hospital , United Kingdom , Alischera Cottrill , Danielle Calloway , Elizabeth Janiak , Debra Stulberg , Kayla Rasmussen , American Academy Of Family Physicians , Irving Harris Foundation , University Of Chicago Medicine Biological Sciences , Duchossois Center , Department Of Family Medicine , University Of Chicago Medicine , Cancer Center , Sciences Division , Harvard Medical School , University Of Chicago Medical Center , Cambridge Reproductive Health Consultants , American College Of Obstetricians , Pritzker School Of Medicine , Parenthood League , Chicago Medicine ,